系统性红斑狼疮伴发肝脾γδT细胞淋巴瘤1例并文献复习

DOI: 10.6040/j.issn.1671-7554.0.2018.099

Keywords: 系统性红斑狼疮,T细胞,淋巴瘤,

Full-Text   Cite this paper   Add to My Lib

Abstract:

References

[1]	King JK, Costenbader KH. Characteristics of patients with systemic lupus erythematosus and non-Hodgkins lymphoma[J]. Clin Rheumatol, 2007, 26(9):1491-1494.
[2]	Bollard CM, Gottschalk S, Torrano S, et al. Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting epstein-barr virus latent membrane proteins[J]. J Clin Onc, 2014, 32(8):798-808.
[3]	Willemze R, Jansen PM, Cerroni L, et al. Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC cutaneous lymphoma group study of 83 cases[J]. Blood, 2008, 111(2): 838-845.
[4]	Lu M, Bernatsky S, Ramsey-Goldman R, et al. Non-lymphoma hematological malignancies in systemic lupus erythematosus[J]. Oncology, 2013, 85(4): 235-240.
[5]	Cerhan JR, Kricker A, Paltiel O, et al. Medical history, lifestyle, family history, and occupational risk factors for diffuse large B-cell lymphoma: the InterLymph non-Hodgkin lymphoma subtypes project[J]. J Natl Cancer Inst Monogr, 2014, 2014(48): 15-25.doi: 10.1093/jncimonographs/lgu010.
[6]	Bernatsky S, Ramsey-Goldman R, Rajan R, et al. Non-Hodgkins lymphoma in systemic lupus erythematosus[J]. Ann Rheum Dis, 2005, 64(10):1507-1509.
[7]	Hanlon P, Avenell A, Aucott L, et al. Systematic review and meta-analysis of the sero-epidemiological association between Epstein-Barr virus and systemic lupus erythematosus[J]. Arthritis Res & Ther, 2014, 16(1):R3.
[8]	Tessier-Cloutier B, Clarke AE, Ramsey-Goldman R, et al. Systemic lupus erythematosus and malignancies: a review article[J]. Rheum Dis Clin North Am, 2014, 40(3): 497-506.
[9]	Koff JL, Flowers CR. B cells gone rogue: the intersection of diffuse large B cell lymphoma and autoimmune disease[J]. Expert Rev Hematol, 2016, 9(6): 553-556.
[10]	Apor E, OBrien J, Stephen M, et al. Systemic lupus erythematosus is associated with increased incidence of hematologic malignancies: a metaanalysis of prospective cohort studies[J]. Leuk Res, 2014, 38(9): 1067-1071.
[11]	Jesus AA, Jacob CM, Silva CA, et al. Common variable immunodeficiency associated with hepatosplenic T-cell lymphoma mimicking juvenile systemic lupus erythematosus[J]. Clin Dev Immunol, 2011, 2011: 428703. doi: 10.1155/2011/428703.
[12]	Yao X, Huang J, Zhong H, et al. Targeting interleukin-6 in inflammatory autoimmune diseases and cancers[J]. Pharmacol & Therap, 2014, 141(2): 125-139.
[13]	Miaer-Moore JS, Horton CG, Mathews SA, et al. Interleukin-6 deficiency corrects nephritis, lymphocyte abnormalities, and secondary sj？grens syndrome features in lupus-prone Sle1.yaa mice[J]. Arthritis Rheum, 2014, 66(9): 2521-2531.
[14]	Capone G, Fasano C, Lucchese G, et al. EBV-associated cancer and autoimmunity: searching for therapies[J]. Vaccines, 2015, 3(1):74-89.
[15]	Suzuki A, Shoji N, Aoki N, et al. Systemic lupus erythematosus as the concomitant manifestation of angioimmunoblastic T-cell lymphoma[J]. Mod Rheumatol, 2017, 27(2):360-363.

Full-Text